Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Mucosal Immunology
|
September 18, 2014
Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites
B Platzer, K Baker, M P Vera, et al.
The British Journal of Dermatology
|
June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
Yael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
Archives of Dermatological Research
|
March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI
Hee J Kim, Ester Del Duca, Ana B Pavel, et al.
Angewandte Chemie (International Ed. in English)
|
April 3, 2024
PyrAtes: Modular Organic Salts with Large Stokes Shifts for Fluo-rescence Microscopy
Iakovos Saridakis, Margaux Riomet, Oliver J V Belleza, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Chemical Science
|
March 12, 2025
Fluorescent PyrAte-(<i>S</i>)-citalopram conjugates enable imaging of the serotonin transporter in living tissue
Oliver J V Belleza, Iakovos Saridakis, Nadja K Singer, et al.
Journal of the American Academy of Dermatology
|
January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Emma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Hospital Pharmacy
|
November 4, 2024
Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers
Sarah K Singer, Kevin D Betthauser, Alexandra E Barber, et al.
The Journal of Allergy and Clinical Immunology
|
August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Patrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Mucosal Immunology
|
September 18, 2014
Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites
B Platzer, K Baker, M P Vera, et al.
The British Journal of Dermatology
|
June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
Yael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
Archives of Dermatological Research
|
March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI
Hee J Kim, Ester Del Duca, Ana B Pavel, et al.
Angewandte Chemie (International Ed. in English)
|
April 3, 2024
PyrAtes: Modular Organic Salts with Large Stokes Shifts for Fluo-rescence Microscopy
Iakovos Saridakis, Margaux Riomet, Oliver J V Belleza, et al.
Archives of Dermatological Research
|
March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Chemical Science
|
March 12, 2025
Fluorescent PyrAte-(<i>S</i>)-citalopram conjugates enable imaging of the serotonin transporter in living tissue
Oliver J V Belleza, Iakovos Saridakis, Nadja K Singer, et al.
Journal of the American Academy of Dermatology
|
January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Emma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Hospital Pharmacy
|
November 4, 2024
Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers
Sarah K Singer, Kevin D Betthauser, Alexandra E Barber, et al.
The Journal of Allergy and Clinical Immunology
|
August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Patrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
Page
of 9